EUVIMEDEUVIMED entdecken
Crossref

SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease

Tianchi Wan iD, Chunkai Wang iD

Journal of Alzheimer’s Disease · 2025-02 · 103 (3) · 941-950

DOI: 10.1177/13872877241307337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 10.01.2025. Verfasst von Tianchi Wan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Calcium-Binding Proteins, Neuroinflammatory Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD), the leading cause of dementia, is characterized by cognitive decline and the accumulation of amyloid-β (Aβ). It affects millions, with numbers expected to double by 2050. SMOC2, implicated in inflammation and fibrosis, may play a role in AD pathogenesis, particularly in microglial cell function, offering a potential therapeutic target.

Objective

Alzheimer's disease (AD) leads to neurodegeneration, affecting cognition, language, and personality, underscoring the urgency for effective treatments. Our study investigates the role of secreted modular calcium-binding protein 2 (SMOC2) in microglial cells and its impact on AD pathology.

Methods

We introduced SMOC2 overexpression and interference vectors into microglial cells treated with Aβ. Activity and phagocytosis were assessed using CCK8 and flow cytometry. SMOC2 mRNA levels were quantified by qPCR, and protein levels of SMOC2, TGF-β1, p-NF-κB/NF-κB were analyzed by western blot. Aβ content was determined by ELISA, and immunofluorescence detected TNF-α, IL-1β, CD163, and CD206.

Results

Aβ treatment inhibited microglial activity and phagocytosis, but SMOC2 disruption enhanced these functions (p < 0.05). SMOC2 overexpression increased its expression and Aβ levels, while interference reduced them (p < 0.001). SMOC2 overexpression also decreased TGF-β1, CD163, and CD206, and increased p-NF-κB/NF-κB, TNF-α, and IL-1β (p < 0.05).

Conclusions

SMOC2 plays a crucial role in microglial cell activity, phagocytosis, and polarization, potentially through the TGF-β1/NF-κB pathway, offering insights into AD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaAlzheimer DiseaseCalcium-Binding ProteinsNeuroinflammatory DiseasesAmyloid beta-PeptidesPhagocytosisAnimalsHumansInflammationMice

Stichwörter der Autor:innen

Alzheimer's diseaseNF-κBSMOC2TGF-β1amyloid-β proteinmicroglia

Substanzen

Calcium-Binding ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Tianchi Wan, Chunkai Wang

Zitieren

APA

Wan, T., & Wang, C. (2025). SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease. Journal of Alzheimer’s Disease, 103(3), 941-950. https://doi.org/10.1177/13872877241307337

Vancouver

Wan T, Wang C. SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease. Journal of Alzheimer’s Disease. 2025;103(3):941-950. doi:10.1177/13872877241307337

BibTeX
@article{Wan2025,
  author = {Wan, Tianchi and Wang, Chunkai},
  title = {SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  volume = {103},
  number = {3},
  pages = {941--950},
  doi = {10.1177/13872877241307337}
}
Kostenlos starten →